0.101
price down icon7.42%   -0.0081
after-market After Hours: .11 0.009 +8.91%
loading
Tnf Pharmaceuticals Inc stock is traded at $0.101, with a volume of 44.76M. It is down -7.42% in the last 24 hours and down -18.22% over the past month. TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms, Isomyosamine and Supera-CBD. Isomyosamine is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B. The company has one reportable segment focused on Isomyosamine.
See More
Previous Close:
$0.1091
Open:
$0.1
24h Volume:
44.76M
Relative Volume:
1.76
Market Cap:
$1.43M
Revenue:
-
Net Income/Loss:
$-23.66M
P/E Ratio:
-0.0073
EPS:
-13.84
Net Cash Flow:
$-10.14M
1W Performance:
-13.53%
1M Performance:
-18.22%
6M Performance:
-88.52%
1Y Performance:
-94.85%
1-Day Range:
Value
$0.09
$0.1069
1-Week Range:
Value
$0.09
$0.1739
52-Week Range:
Value
$0.0849
$2.16

Tnf Pharmaceuticals Inc Stock (TNFA) Company Profile

Name
Name
Tnf Pharmaceuticals Inc
Name
Phone
856-848-8698
Name
Address
1185 AVENUE OF THE AMERICAS, NEW YORK
Name
Employee
2
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
TNFA's Discussions on Twitter

Compare TNFA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TNFA
Tnf Pharmaceuticals Inc
0.101 1.77M 0 -23.66M -10.14M -13.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.46B 3.81B -644.79M -669.77M -6.24

Tnf Pharmaceuticals Inc Stock (TNFA) Latest News

pulisher
03:21 AM

TNF Pharmaceuticals Inc: Weathering Stock Market Storms with 1.34M Market Cap - investchronicle.com

03:21 AM
pulisher
06:08 AM

Regression analysis insights on TNF Pharmaceuticals Inc. performanceEntry Zone Watchlist With Momentum Focus - Newser

06:08 AM
pulisher
03:45 AM

Can TNF Pharmaceuticals Inc. rally from current levelsFree Trade Ready Stock Watch for Short Term - Newser

03:45 AM
pulisher
Jul 31, 2025

Signal strength of TNF Pharmaceuticals Inc. stock in tech scannersFree Risk Controlled Picks With Real Returns - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Why TNF Pharmaceuticals Inc. stock attracts strong analyst attentionPredictive AI Signals for Short-Term Trading - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What are the latest earnings results for TNF Pharmaceuticals Inc.Daily Trading Forecasts From AI Tools - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What is the risk reward ratio of investing in TNF Pharmaceuticals Inc. stockExpert Picks Outlook For Beginners - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Is TNF Pharmaceuticals Inc. stock overvalued or undervaluedAI Powered Entry Points That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

How TNF Pharmaceuticals Inc. stock performs during market volatilityFundamental Forecast for Undervalued Stocks - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Analyzing TNF Pharmaceuticals Inc. with multi timeframe chartsMomentum Stocks with Breakout Potential - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Why Did TNF Pharmaceuticals (TNFA.O) Plummet 19.8% in a Day with No New News? - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

TNF Pharmaceuticals Plunges 12.34% Amid Bearish Outlook - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

What candlestick patterns are forming on TNF Pharmaceuticals Inc.Market Ready Picks with Technical Support - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Using RSI to spot recovery in TNF Pharmaceuticals Inc.Exit Strategy Guide With Risk Control Plan - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Detecting price anomalies in TNF Pharmaceuticals Inc. with AIRisk Adjusted Trade Signal Screening Tool - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Will TNF Pharmaceuticals Inc. see short term momentumPrice Action Summary and Entry Strategy Guide - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

TNF Pharmaceuticals Stock Soars 6.4% on Short Squeeze Speculation - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

What institutional investors are buying TNF Pharmaceuticals Inc. stockRetirement Planning Insights For 2025 - jammulinksnews.com

Jul 29, 2025
pulisher
Jul 28, 2025

What makes TNF Pharmaceuticals Inc. stock price move sharplyAI Volatility Forecast and Risk Monitor - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 17:03:00 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate TNF Pharmaceuticals Inc. as a “Buy”Maximize returns with smart investment plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What are TNF Pharmaceuticals Inc. company’s key revenue driversUnlock exclusive stock market insights - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell TNF Pharmaceuticals Inc. stock in 2025Free Investment Case Studies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy TNF Pharmaceuticals Inc. stockHigh-performance stocks for savvy investors - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is TNF Pharmaceuticals Inc. company’s growth strategyStay ahead with daily expert stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does TNF Pharmaceuticals Inc. compare to its industry peersCapitalize on emerging trends for profits - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

TNF Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayHigh Accuracy Alerts - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is TNF Pharmaceuticals Inc. a good long term investmentOutstanding capital appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives TNF Pharmaceuticals Inc. stock priceAccelerated earnings growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

TNF Pharmaceuticals Plunges 9.09% Amid Patent Concerns - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Best Stocks in India for Inflation Protection Stock Trend Prediction ToolsTriple-digit profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about TNF Pharmaceuticals Inc. stockHigh-profit capital plays - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Company Inc. stock priceHigh-return market picks - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

TNF Pharmaceuticals Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives KTOS stock priceFree Predictions - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Global Indemnity Group LLC Preferred Security Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional

Jul 23, 2025

Tnf Pharmaceuticals Inc Stock (TNFA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):